Abbvie pays up to €895m for Irish funded dementia drug group
Belgian company Syndesi Therapeutics was backed by Irish VC Fountain Healthcare on spin-out
Belgian company Syndesi Therapeutics was backed by Irish VC Fountain Healthcare on spin-out
Neuromod welcomes independent real-world study confirming clinical trial data
Company completes dosing in first round of trial of treatment for coeliac disease
Funding will drive commercialisation of Reactiv8 in critical US market
Galway-based Neurent looks to capitalise on treatment for one of the most common chronic conditions
Galway medical device group sees $2bn market for novel rhinitis device
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Large-scale trial shows improvement after 12 weeks, sustained results after 12 months
Cantillon: Venture capital business sells Inflazome to Roche for €380m
Company developing medicines for chronic inflammatory diseases such as Alzheimer’s
Acquisition of KaNDy Therapeutics a win for Irish VC investor Fountain Healthcare
Fountain Healthcare invests in French start-up Inotrem which targets condition with 35% mortality rate
Bank debt isn’t the only game in town for businesses. Here are some alternatives
Company plans to ramp up commercialisation of tinnitus treatment
Group beats €100m target and intends to invest the bulk of the fund in Europe and US
Figures from Mergermarket show the value of transactions jumped 370% in 2018
Seen and heard: PwC to review children’s hospital costs, ESB may offload Dublin depot
Inflazome in one of the largest European biotech fundraisings this year as it targets range of serious inflammatory diseases
After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market
Irish healthcare venture capital group Fountain among backers of HRT alternative
Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device
Galway medical device firm developing rhinitis cure device for use in doctors’ offices
Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer
Fountain Healthcare participates in €17m funding round for Syndesi Therapeutics
Irish medtech start-up seeking to commercialise non-invasive device for condition
Dublin-listed medical devices firm recently made its first commercial sale in Germany
Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009
Iseq-listed medical device firm targets commercial growth and completion of US clinical trials
Dublin-listed firm pushes ahead with plans to commercialise back pain treatment
Company’s flagship product ReActiv8 won European approval earlier this year
Chrono Therapeutics developing device to deliver nicotine through skin in timed doses
Start-up’s technology allows surgeons to finish heart surgery without leaving stitches
Operating expenses also decline while R&D and clinical and regulatory costs rise
Firm developing products to treat postoperative pain and diabetic foot infections
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices